Common Stock Purchase Warrant Sample Contracts

Common Stock Purchase Warrant General Moly, Inc. (October 19th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the Warrant) certifies that, for value received, or its assigns (the Holder) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the Initial Exercise Date) and on or prior to 5:00 p.m. (New York City time) on (1) (the Termination Date) but not thereafter, to subscribe for and purchase from General Moly, Inc., a Delaware corporation (the Company), up to shares (as subject to adjustment hereunder, the Warrant Shares) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Lm Funding America, Inc. – Common Stock Purchase Warrant Lm Funding America, Inc. (October 17th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, Maxim Group, LLC or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [__](the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on [__] (the "Termination Date") but not thereafter, to subscribe for and purchase from LM Funding America, Inc., a Delaware corporation (the "Company"), up to [] shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

ADVANCED MEDICAL ISOTOPE Corp – Common Stock Purchase Warrant Vivos, Inc. (October 17th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to the close of business on the two year anniversary of the Initial Exercise Date (the "Termination Date") but not thereafter, to subscribe for and purchase from Vivos, Inc., a Delaware corporation (the "Company"), up to shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Lm Funding America, Inc. – Common Stock Purchase Warrant Lm Funding America, Inc. (October 17th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, Maxim Group, LLC or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [__](the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on [__] (the "Termination Date") but not thereafter, to subscribe for and purchase from LM Funding America, Inc., a Delaware corporation (the "Company"), up to [] shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Lm Funding America, Inc. – Pre-Funded Common Stock Purchase Warrant Lm Funding America, Inc. (October 17th, 2018)

THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, [] or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and until this Warrant is exercised in full (the "Termination Date") but not thereafter, to subscribe for and purchase from LM Funding America, Inc., a Delaware corporation (the "Company"), up to [] shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Medovex – COMMON STOCK PURCHASE WARRANT Medovex Corp. (October 15th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to the close of business on the three year anniversary of the Initial Exercise Date (the "Termination Date") but not thereafter, to subscribe for and purchase from Medovex Corp., a Nevada corporation (the "Company"), up to ______1 shares (the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

SERIES C COMMON STOCK PURCHASE WARRANT BTCS Inc. Expires October 11, 2022 (October 12th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, [*] or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after October 11, 2018 (the "Initial Exercise Date") and on or prior to the close of business on October 11, 2022 (the "Termination Date") but not thereafter, to subscribe for and purchase from BTCS Inc., a Nevada corporation (the "Company"), up to 13,750,000 shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Common Stock Purchase Warrant Bridgeline Digital, Inc. (October 12th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after _____, 2018 (the "Initial Exercise Date") and on or prior to the close of business on the five (5) year anniversary of the Initial Exercise Date (the "Termination Date") but not thereafter, to subscribe for and purchase from Bridgeline Digital, Inc., a Delaware corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

COMMON STOCK PURCHASE WARRANT Magnegas APPLIED TECHNOLOGY SOLUTIONS, INC. (October 11th, 2018)

This COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, [_______________________]., a [____] corporation or assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, on the Initial Exercise Date (as defined below) and on or prior to the close of business on the date that is forty two (42) months from the Closing Date (the "Termination Date") but not thereafter, to subscribe for and purchase from MagneGas Applied Technology Solutions, Inc., a Delaware corporation (the "Company"), up to [ ] shares (as subject to adjustment hereunder, the "Warrant Shares") of the Company's common stock, par value $0.001 per share (the "Common Stock"). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 1(b).

EpiCept Corporation – Common Stock Purchase Warrant Immune Pharmaceuticals Inc. (October 10th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (this "Warrant") certifies that, for value received, __________________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issuance Date and on or prior to the close of business on the 3-year anniversary of the Issuance Date (the "Termination Date") but not thereafter, to subscribe for and purchase from Immune Pharmaceuticals Inc., a Delaware corporation (the "Company"), up to the number of Warrant Shares of Common Stock stated above. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Targeted Genetics Corporation – Pre-Funded Common Stock Purchase Warrant Ampliphi Biosciences Corporation (October 9th, 2018)

THIS PRE-FUNDED WARRANT TO PURCHASE COMMON STOCK (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [ISSUE DATE] (the "Initial Exercise Date") until this Warrant is exercised in full (the "Termination Date") but not thereafter, to subscribe for and purchase from AmpliPhi Biosciences Corporation, a Washington corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the aggregate exercise price, as described in Section 2(b).

Targeted Genetics Corporation – Common Stock Purchase Warrant Ampliphi Biosciences Corporation (October 9th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and until 5:00 p.m. (New York City time) on ______________1 (the "Termination Date") but not thereafter, to subscribe for and purchase from AmpliPhi Biosciences Corporation, a Washington corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Common Stock Purchase Warrant (October 9th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (this "Warrant") certifies that, for value received, __________________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Initial Exercise Date and on or prior to the close of business on the 3-year anniversary of the Initial Exercise Date (the "Termination Date") but not thereafter, to subscribe for and purchase from Beyond Commerce, Inc., a Nevada corporation (the "Company"), up to the number of Warrant Shares of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

RXi Pharmaceuticals Corp – UNDERWRITER COMMON STOCK PURCHASE WARRANT RXi Pharmaceuticals Corporation (October 5th, 2018)

THIS UNDERWRITER COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on October 1, 2023 (the "Termination Date") but not thereafter, to subscribe for and purchase from RXi Pharmaceuticals Corporation, a Delaware corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to the Registration Statement which Registration Statement also registers the Warrant Shares issuable upon exercise of this Warrant.

Common Stock Purchase Warrant Air Industries Group (October 4th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received RBI Private Investment III, LLC or assigns (the "Holder"), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or prior to the close of business on September 30, 2023 (the "Termination Date") but not thereafter, to subscribe for and purchase from Air Industries Group, a Nevada corporation (the "Company"), up to two hundred eighty thousand (280,000) shares (the "Warrant Shares)," of the Company's common stock ("Common Stock"), as subject to adjustment hereunder,. The exercise price per share of the Common Stock under this Warrant shall be One Dollar and Forty Cents ($1.40), subject to adjustment hereunder (the "Exercise Price").

Skyline Medical Inc. – Common Stock Purchase Warrant Precision Therapeutics Inc. (October 4th, 2018)

HIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received (in connection with the funding of the purchase price of $600,000, with respect to the first tranche of $681,818.80 under that certain convertible promissory note in the original principal amount of $852,273.25 on September 28, 2018 by the Company (as defined below) to the Holder (as defined below)) (the "Note"), Peak One Opportunity Fund, LP, a Delaware limited partnership (including any permitted and registered assigns, the "Holder"), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from Precision Therapeutics Inc., a Delaware corporation (the "Company"), up to 397,544 shares of Common Stock (as defined below) (the "Warrant Shares") (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) (with the understanding that the H

Skyline Medical Inc. – Common Stock Purchase Warrant Precision Therapeutics Inc. (October 4th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received (in connection with the funding of the purchase price of $1,400,000.00, with respect to the first tranche of $1,615,908.70 under that certain convertible promissory note in the original principal amount of $2,013,635.75 on September 28, 2018 by the Company (as defined below) to the Holder (as defined below)) (the "Note"), L2 Capital, LLC, a Kansas limited liability company (including any permitted and registered assigns, the "Holder"), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from Precision Therapeutics Inc., a Delaware corporation (the "Company"), up to 939,261 shares of Common Stock (as defined below) (the "Warrant Shares") (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) (with the understanding that the H

Common Stock Purchase Warrant Iconic Brands, Inc. (October 4th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Reverse Stock Split Date (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on the five (5) year anniversary of the Initial Exercise Date (the "Termination Date") but not thereafter, to subscribe for and purchase from Iconic Brands, Inc., a Nevada corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Pre-Funded Common Stock Purchase Warrant (October 3rd, 2018)

THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after September __, 2018 (the "Initial Exercise Date") until this Warrant is exercised in full (the "Termination Date") but not thereafter, to subscribe for and purchase from MoSys, Inc., a Delaware corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Aytu Bioscience, Inc – COMMON STOCK PURCHASE WARRANT Aytu BioScience, Inc. (October 3rd, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on _____1 (the "Termination Date") but not thereafter, to subscribe for and purchase from Aytu BioScience, Inc., a Delaware corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee ("DTC") shall initially be the sole registered holder of this Warrant, subject to a Holder's right to

Common Stock Purchase Warrant (October 3rd, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after October __, 2018 (the "Initial Exercise Date") and on or prior to the close of business on the five (5) year anniversary of the Initial Exercise Date (the "Termination Date"; provided, however, that if such date is not a Trading Day, the Termination Date shall be the immediately following Trading Day) but not thereafter, to subscribe for and purchase from MoSys, Inc., a Delaware corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Kala Pharmaceuticals, Inc. – Kala Pharmaceuticals, Inc. Common Stock Purchase Warrant (October 2nd, 2018)

THIS IS TO CERTIFY that ATHYRIUM OPPORTUNITIES III ACQUISITION LP, a Delaware limited partnership, and its permitted transferees, successors and permitted assigns (the Holder), for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, is entitled to purchase from KALA PHARMACEUTICALS, INC., a Delaware corporation (the Company), at the price of $12.18456 per share (the Exercise Price), at any time after the date hereof (the Commencement Date) and expiring on October 1, 2025 (the Expiration Date), 270,835 shares of the fully paid and non-assessable common stock, par value $0.001 per share (Common Stock), of the Company (as such number may be adjusted as provided herein). The 270,835 shares of Common Stock which may be purchased pursuant to this Warrant are referred to herein as the Aggregate Number. This common stock purchase warrant (this Warrant) is issued under and pursuant to that certain Credit Agreement by and among the Company, the Holder

Monaker Group, Inc. – FORM OF COMMON STOCK PURCHASE WARRANT Monaker Group, Inc. (October 2nd, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on October 2, 2023 (the "Termination Date") but not thereafter, to subscribe for and purchase from Monaker Group, Inc., a Nevada corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

SONUS Pharmaceuticals, Inc. – Common Stock Purchase Warrant Achieve Life Sciences, Inc. (October 1st, 2018)
Uranium Energy – Common Stock Purchase Warrant Uranium Energy Corp. (October 1st, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the Warrant) certifies that, for value received, _____________ or its assigns (the Holder) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after October 3, 2018 (the Initial Exercise Date) and on or prior to the close of business on the day which is 30 months from the Issue Date (the Termination Date) but not thereafter, to subscribe for and purchase from Uranium Energy Corp., a Nevada corporation (the Company), up to <> shares (as subject to adjustment hereunder, the Warrant Shares) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Series B Pre-Funded Common Stock Purchase Warrant Invivo Therapeutics Holdings Corp. (September 28th, 2018)

THIS SERIES B PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, CEDE & CO. or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on June 25, 2038 (the "Termination Date") but not thereafter, to subscribe for and purchase from InVivo Therapeutics Holdings Corp., a Nevada corporation (the "Company"), up to 6,242,811 shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. Notwithstanding the foregoing, the Termination Date shall be tolled and extended on a day-by-day basis to the extent that the exercise by a Holder of this Warrant on the Termination Date would exceed the Beneficial Ownership Limitation set forth in Section 2(e) hereof. The purchase price of one share of Common Stock under this Warrant shall be equ

Common Stock Purchase Warrant Mosys, Inc. (September 28th, 2018)
Pre-Funded Common Stock Purchase Warrant Mosys, Inc. (September 28th, 2018)
RXi Pharmaceuticals Corp – COMMON STOCK PURCHASE WARRANT RXi Pharmaceuticals Corporation (September 28th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on ______________1 (the "Termination Date") but not thereafter, to subscribe for and purchase from RXi Pharmaceuticals Corporation, a Delaware corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to the Registration Statement which Registration Statement also registers the Warrant Shares issuable upon exercise of this Warrant.

Series a Common Stock Purchase Warrant Invivo Therapeutics Holdings Corp. (September 28th, 2018)

THIS SERIES A COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, CEDE & CO. or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on June 26, 2023 (the "Termination Date") but not thereafter, to subscribe for and purchase from InVivo Therapeutics Holdings Corp., a Nevada corporation (the "Company"), up to 7,621,211 shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee ("DTC") shall initially be the sole registered holder of this Warrant, subj

Songbird Development Inc. – COMMON STOCK PURCHASE WARRANT Dthera Sciences (September 27th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, ICONIC VENTURES, LLC or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after September 21, 2018 (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on September 21, 2023 (the "Termination Date") but not thereafter, to subscribe for and purchase from Dthera Sciences, a Nevada corporation (the "Company"), up to 2,000,000 shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Jolley Marketing Inc – COMMON STOCK PURCHASE WARRANT Creative Medical Technology Holdings, Inc. (September 27th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, Global Capital Partners Group, LLC or its registered assigns (the "Holder"), with an address at: 1361 East 10th Street, Brooklyn, NY 11730, or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to the close of business on the fifth anniversary of the Issuance Date (the "Termination Date") but not thereafter, to subscribe for and purchase from Creative Medical Technology Holdings, Inc., a Nevada corporation (the "Company"), up to 1,247,618 shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Cannabics Pharmaceuticals Inc. – COMMON STOCK PURCHASE WARRANT CANNABICS Pharmaceuticals INC. (September 27th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on September 26, 2023 (the "Termination Date") but not thereafter, to subscribe for and purchase from Cannabics Pharmaceuticals Inc., a Nevada corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of the Company's common stock (the "Common Stock"). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Aytu Bioscience, Inc – COMMON STOCK PURCHASE WARRANT Aytu BioScience, Inc. (September 25th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on _____1 (the "Termination Date") but not thereafter, to subscribe for and purchase from Aytu BioScience, Inc., a Delaware corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee ("DTC") shall initially be the sole registered holder of this Warrant, subject to a Holder's right to

Aytu Bioscience, Inc – COMMON STOCK PURCHASE WARRANT Aytu BioScience, Inc. (September 25th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on _____1 (the "Termination Date") but not thereafter, to subscribe for and purchase from Aytu BioScience, Inc., a Delaware corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).